MetaCap

Who Owns ImmunityBio Stock?

NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.02-0.55 (-8.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
20.47%
Institutional holders
516
  • Institutions 20.5%
  • Insiders 62.1%
  • Public and other 17.4%

Who owns ImmunityBio stock?

Institutional investors own about 20.5% of ImmunityBio's shares, spread across 516 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 62.13% of IBRX.

The largest institutional holders are Blackrock Inc. (3.40%), State Street Corporation (1.98%) and Vanguard Portfolio Management LLC (1.82%). Together, the top 10 institutions control 13.3% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their IBRX positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of IBRX

ImmunityBio top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.36.12M3.40%+6.0%
State Street Corporation21.10M1.98%-1.4%
Vanguard Portfolio Management LLC19.39M1.82%+8.5%
Vanguard Capital Management LLC18.80M1.77%+19.8%
Shaw D.E. & Co., Inc.11.55M1.09%-8.1%
Two Sigma Investments, LP11.10M1.04%+153.0%
Geode Capital Management, LLC10.61M1.00%+7.7%
Millennium Management Llc5.58M0.52%+292.9%
UBS Group AG3.78M0.35%+18.1%
Northern Trust Corporation3.57M0.34%+42.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of IBRX

ImmunityBio top fund holders
FundShares% Held
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF11.70M1.10%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund11.60M1.09%
iShares Trust-iShares Russell 2000 ETF9.99M0.94%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund8.40M0.79%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund4.85M0.46%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund4.23M0.40%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund3.73M0.35%
iShares Trust-iShares Russell 2000 Growth ETF3.62M0.34%
iShares Trust-iShares Biotechnology ETF3.07M0.29%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund2.21M0.21%

Frequently asked questions

Who is the largest shareholder of ImmunityBio?

Blackrock Inc. is the largest institutional shareholder of IBRX, owning 3.40% of shares outstanding (36.12M shares) as of its latest 13F filing.

What percentage of ImmunityBio is owned by institutions?

Institutions own about 20.5% of IBRX shares and 54.1% of the public float.

How much of ImmunityBio do insiders own?

Insiders, such as officers and directors, own about 62.13% of IBRX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related